Alex Weymouth-Wilson
Technik-/Wissenschafts-/F&E-Leiter bei New Zealand Pharmaceuticals Ltd.
Profil
Alex Weymouth-Wilson is currently the Chief Scientific Officer at New Zealand Pharmaceuticals Ltd.
He previously worked as a Principal at PMC Isochem SAS and CMS Alphatech Ltd.
Dr. Weymouth-Wilson received his undergraduate and graduate degrees from The University of Reading and his doctorate in 1993 from the same institution.
Aktive Positionen von Alex Weymouth-Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
New Zealand Pharmaceuticals Ltd.
 New Zealand Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology New Zealand Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical intermediates and diagnostic products for pharmaceutical and biotechnology companies. Its products include pharmaceutical intermediates and ingredients, excipients, carbohydrates, dietary supplements, and feed ingredients. The company was founded in 1971 and is headquartered in Palmerston North, New Zealand. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Ehemalige bekannte Positionen von Alex Weymouth-Wilson
| Unternehmen | Position | Ende |
|---|---|---|
| CMS Alphatech Ltd. | Corporate Officer/Principal | - |
PMC Isochem SAS
 PMC Isochem SAS Chemicals: SpecialtyProcess Industries Part of PMC Group, Inc., PMC Isochem SAS operates as a contract manufacturer and supplier of fine chemicals and active pharmaceutical ingredients. The company is based in Vert-Le-Petit, France. PMC Isochem was acquired by PMC Group, Inc. on November 22, 2017. | Corporate Officer/Principal | - |
Ausbildung von Alex Weymouth-Wilson
| The University of Reading | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
PMC Isochem SAS
PMC Isochem SAS Chemicals: SpecialtyProcess Industries Part of PMC Group, Inc., PMC Isochem SAS operates as a contract manufacturer and supplier of fine chemicals and active pharmaceutical ingredients. The company is based in Vert-Le-Petit, France. PMC Isochem was acquired by PMC Group, Inc. on November 22, 2017. | Process Industries |
New Zealand Pharmaceuticals Ltd.
New Zealand Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology New Zealand Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical intermediates and diagnostic products for pharmaceutical and biotechnology companies. Its products include pharmaceutical intermediates and ingredients, excipients, carbohydrates, dietary supplements, and feed ingredients. The company was founded in 1971 and is headquartered in Palmerston North, New Zealand. | Health Technology |
| CMS Alphatech Ltd. |
